In Des Plaines, Illinois, where long winters and a hearty food culture make weight management an uphill battle, Semaglutide is commonly prescribed for medically supervised weight management. Weight Method's separate program prescribes compounded Semaglutide (dispensed by U.S.-licensed 503A pharmacies and not FDA-approved; the FDA-approved branded products are Ozempic / Wegovy) through virtual consultations with providers licensed in Illinois, delivering medication directly to Des Plaines at $199/month with the provider evaluation, ongoing care, and shipping included.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Des Plaines is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Des Plaines, IL. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
For many people in Des Plaines, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide (Ozempic / Wegovy) addresses the hormonal drivers of excess weight, helping your body regulate appetite at the source. Weight Method's telehealth program brings this treatment to Illinois residents with a streamlined process: complete an online assessment, consult with a licensed provider, and receive your Semaglutide shipped directly to your Des Plaines address. Average weight loss in clinical trials is 15-20% of body weight of body weight over 12-18 months.
Hispanic adults in Des Plaines face disproportionately high rates of obesity and type 2 diabetes, conditions that Semaglutide is specifically designed to treat. Weight Method removes the barriers that have historically limited access — language, cost, and insurance requirements. Our platform is fully bilingual, Semaglutide starts at $199/month with no insurance needed, and everything happens virtually from your Des Plaines home.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Illinois and start Semaglutide from $199/month.
Get Started NowFree consultation. No commitment.